ROI Analysis of the Tumor Management System

November 21, 2022

ROI Analysis of the Tumor Management System

Cem Girit1
Biopticon Corporation, Plainsboro, NJ 08536. Corresponding author.


The Tumor Management System consists of the TumorImagerTM, used for rapidly and noninvasively imaging subcutaneous tumors on un-anesthetized mice used in preclinical oncology studies, and TumorManagerTM, a comprehensive study management program that integrates seamlessly with the TumorImagerTM system and other devices (including calipers) for managing all aspects of a study from protocol creation, data acquisition and analysis, to final reports.

Read Full Article